Current Edition

ASH 2014: A Mirror on Progress, Challenges and Opportunity for New Therapies in Haematologic Malignancies

“For the eighth consecutive year, my colleagues and I have had the good fortune to attend the Annual Meeting of the American Society for Hematology (ASH).” Nicholas Kenny PhD, Executive Vice President and General Manager from INC Research, shares his researches and experiences within this white paper regarding the progress, challenges, and opportunity for new therapies in haematologic malignancies.